☰
×
News
Top 20
Insights
Insights+
ThoughtSpot
Interviews
Viewpoints
Exclusive
Spotlight
Events
Magazine
Bespoke
Newswire
x
Search
Search here
Search here
Subscribe Now
apraglutide
Ironwood Pharmaceuticals Reports Results for Apraglutide in P-III Trial for the Treatment of Short Bowel Syndrome with Intestinal...
March 1, 2024
Ironwood to Acquire VectivBio for ~$1B
May 23, 2023
Load more...
Back to Home
Modal title
×
Modal body text goes here.